Pastāsti draugiem par šo preci:
All About Bevacizumab Krzysztof Krzemieniecki
Cena
€ 37,99
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 22. - 30. okt.
Saņemiet paziņojumus par jauniem Krzysztof Krzemieniecki izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
All About Bevacizumab
Krzysztof Krzemieniecki
Remission during sunitinib (a multikinase inhibitor and antiangiogenic drug) treatment correlates with appearance of macrocytosis. There are some suggestions that bevacizumab, an antiangiogenic drug, may result in macrocytosis as well. No available published data on the influence of bevacizumab on macrocytosis has been so far. This paper attempts to answer the question: does bevacizumab induce macrocytosis being a predictor of the response? Moreover, treatment of solid tumors and non-cancerous diseases is discussed in the second part of this paper.
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2013. gada 27. novembris |
| ISBN13 | 9783659494116 |
| Izdevēji | LAP LAMBERT Academic Publishing |
| Lapas | 72 |
| Izmēri | 150 × 4 × 226 mm · 125 g |
| Valoda | Vācu |